| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/05/1998 | CA2261580A1 Antimicrobial peptides |
| 02/04/1998 | EP0822200A1 Synthesis of analogs of PTH and PTrP |
| 02/04/1998 | EP0821697A1 Method for preparing streptogramines |
| 02/04/1998 | EP0500791B1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |
| 02/03/1998 | US5714579 Technetium-99M labeled peptides for imaging inflammation |
| 02/03/1998 | US5714363 Polypeptide synthetase having the catalytic hydrolysis activity, changing 3-exomethylenecephalosporin c to deacetylcephalosporin c |
| 02/03/1998 | US5714342 Using fluorescence analysis |
| 02/03/1998 | US5714331 Incorporating an aminoalkyl side chain into the pna's which bind to complementary nucleobase sequences more tightly to form ?duplexes?; viricides; anticarcinogenic agents; enzyme inhibitors |
| 02/03/1998 | CA1339659C Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
| 01/29/1998 | WO1998003632A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | WO1998003541A1 Conantokins |
| 01/29/1998 | WO1998003192A1 Cyclic peptides having broad spectrum antimicrobial activity |
| 01/29/1998 | WO1998003189A1 Use of conantokins |
| 01/29/1998 | CA2262008A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | CA2261797A1 Cyclic peptides having broad spectrum antimicrobial activity |
| 01/29/1998 | CA2261570A1 Use of conantokins |
| 01/29/1998 | CA2261568A1 Conantokins |
| 01/28/1998 | EP0821004A1 Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 01/28/1998 | EP0821003A1 Peptides and remedy for autoimmune diseases comprising the same |
| 01/28/1998 | EP0821002A1 Plant cell growth factors |
| 01/28/1998 | EP0820598A1 Assaying protein fragments in body fluids |
| 01/28/1998 | EP0820466A2 Fluorescent peptides |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820313A2 Radiolabeled peptides for diagnosis and therapy |
| 01/28/1998 | EP0820312A1 Ternary radiopharmaceutical complexes |
| 01/28/1998 | EP0474789B1 Cysteine thiol-protected peptides for use in immunoassays |
| 01/28/1998 | CN1171791A Purified thrombopoietin and method of making it |
| 01/27/1998 | US5712417 Inhibitors of retroviral proteases |
| 01/27/1998 | US5712375 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 01/27/1998 | US5712370 Erythropoietin (EPO) peptides and antibodies directed against these |
| 01/27/1998 | US5712367 Coupling with lipophilic substituent |
| 01/27/1998 | US5712251 Treatment method |
| 01/27/1998 | US5711947 Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002192A1 Radiometal-binding peptide analogues |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
| 01/21/1998 | EP0710228B1 Hydrazino-type radionuclide chelators having an n 3?s configuration |
| 01/21/1998 | CN1171118A Fibronectin adhesion inhibitors |
| 01/21/1998 | CN1037104C Novel cyclosporins |
| 01/20/1998 | US5710249 Amino acids and processes for making peptides using same |
| 01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
| 01/20/1998 | US5710246 Coupling oligopeptides; deprotecting |
| 01/20/1998 | US5710130 Heterocyclic synthetic peptides |
| 01/20/1998 | US5710129 Inhibitors of SH2-mediated processes |
| 01/20/1998 | US5710128 Pharmaceutical compositions of lipopolysaccharide-binding polypeptides |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709797 Method of isolating cyclosporins |
| 01/15/1998 | WO1998001558A2 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | WO1998001472A1 Fluorescent peptides |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | CA2259961A1 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817796A1 Cyclic peptide nuclei and derivatives thereof |
| 01/14/1998 | EP0817650A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0659276B1 Immunoassay for detecting collagen or collagen fragments |
| 01/13/1998 | US5708155 Dna construct encoding a chimeric protein |
| 01/13/1998 | US5708153 Preparing a library |
| 01/13/1998 | US5708145 Antibodies |
| 01/13/1998 | US5708135 Cyclic peptide analogs of somatostatin |
| 01/13/1998 | US5707964 Hormone-toxin conjugate, gonadotropin-releasing hormone receptors |
| 01/13/1998 | US5707855 CEMA cationic peptide and polynucleotides encoding cEMA |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/08/1998 | WO1998000538A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 01/08/1998 | WO1998000443A1 Thrombin inhibitors |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000158A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | WO1998000156A1 Synthetic phosphopeptides for treating bone diseases |
| 01/08/1998 | WO1998000153A1 Amides |
| 01/08/1998 | CA2259557A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | CA2259132A1 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/07/1998 | EP0816378A1 Glycopeptide antibiotic amide derivatives |
| 01/07/1998 | EP0816377A2 Peptides which bind to prothrombin and thrombin |
| 01/07/1998 | EP0815873A1 Selective stabilization of proteins by binding to an immobilised affinity ligandduring viral |
| 01/07/1998 | EP0815259A1 Modulation of the binding properties of nucleic acid binding partners |
| 01/07/1998 | EP0815247A1 Method for the production of cationic peptides |
| 01/07/1998 | EP0815139A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 01/07/1998 | EP0815136A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/07/1998 | EP0815135A1 Lipophilic peptide hormone derivatives |
| 01/07/1998 | EP0815134A1 Modulators of amyloid aggregation |
| 01/07/1998 | EP0815128A2 Amphiphilic peptide and analogs thereof |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0815122A1 Process for preparation of pure cyclosporin chromatographically using an eluent consisting essentially of high pressure carbon dioxide |
| 01/07/1998 | EP0778847A4 Immunostimulatory agents |
| 01/07/1998 | EP0750630A4 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/06/1998 | US5705610 Suspension solution, coupling, withdrawal and mixing |